Skip to main content
logo
ABIONYX Pharma SA (EPA:ABNX)
France flag France · Delayed Price · Currency is EUR
1.886
+0.030 (1.62%)
Aug 3, 2026, 12:42 PM CET

ABIONYX Pharma Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4.064.064.554.645.250.68
Revenue Growth
-6.08%-10.72%-1.92%-11.65%678.07%-
Gross Profit
0.530.530.840.620.640.26
Operating Income
-5.54-5.54-4.47-3.41-4.11-5.95
Net Income
-5.55-5.55-4.38-3.52-4.21-5.82
Earnings Per Share
-0.16-0.16-0.13-0.12-0.15-0.23
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3.523.523.244.14.057.94
Total Debt
3.813.812.763.394.014.96
Net Cash (Debt)
-0.28-0.280.480.710.032.98
Net Cash Growth
---33.05%2063.64%-98.89%-67.39%
Net Cash Per Share
-0.01-0.010.010.020.000.12

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.93-2.93-3.63-3.7-3.36-6.69
Capital Expenditures
-0.24-0.24-0.07-0.1-0.17-0.17
Free Cash Flow
-3.18-3.18-3.7-3.8-3.52-6.86
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
13.14%13.14%18.55%13.32%12.11%38.37%
Operating Margin
-136.30%-136.30%-98.11%-73.53%-78.24%-881.78%
Pretax Margin
-136.38%-136.38%-96.26%-75.82%-80.08%-862.52%
Profit Margin
-136.60%-136.60%-96.27%-75.82%-80.08%-862.52%
FCF Margin
-78.14%-78.14%-81.34%-81.94%-67.10%-1016.00%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-9.449.449.449.449.44
PS Ratio
16.1232.869.078.949.23100.22